IMMUNOCORE HOLDINGS PLC - AMERICAN DEPOSITARY SHAR

Immunocore presents three-year overall survival data from the KIMMTRAK Phase 3 trial

21 окт 2023 08:45:00 Источник Nasdaq GlobeNewswire

Immunocore announces upcoming presentation and posters at ESMO 2023

06 окт 2023 07:01:00 Источник Nasdaq GlobeNewswire

Immunocore to present at upcoming investor conferences

11 сен 2023 17:00:00 Источник Nasdaq GlobeNewswire

Immunocore to present at upcoming investor conferences

01 сен 2023 16:00:00 Источник Nasdaq GlobeNewswire

Immunocore Reports Second Quarter 2023 Financial Results and Provides Business Update

10 авг 2023 07:00:00 Источник Nasdaq GlobeNewswire

Immunocore to report second quarter 2023 financial results and host call on August 10, 2023

03 авг 2023 08:00:00 Источник Nasdaq GlobeNewswire

Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO

03 июн 2023 07:00:00 Источник Nasdaq GlobeNewswire

Immunocore to present at upcoming investor conferences

01 июн 2023 16:30:00 Источник Nasdaq GlobeNewswire

Immunocore Reports First Quarter 2023 Financial Results and Provides Business Update

10 май 2023 07:00:00 Источник Nasdaq GlobeNewswire

Immunocore to present at the Bank of America Securities 2023 Health Care Conference

03 май 2023 16:30:00 Источник Nasdaq GlobeNewswire

Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival

18 апр 2023 07:00:00 Источник Nasdaq GlobeNewswire

Immunocore to present at the 22nd Annual Needham Virtual Healthcare Conference

11 апр 2023 07:00:00 Источник Nasdaq GlobeNewswire

Immunocore to present four posters at AACR Annual Meeting 2023

14 мар 2023 16:30:00 Источник Nasdaq GlobeNewswire

Immunocore Reports 2022 Financial Results and Provides Business Update

01 мар 2023 07:00:00 Источник Nasdaq GlobeNewswire

Immunocore to Report Fourth Quarter and Full Year 2022 Earnings and Host Call on March 1, 2023

23 фев 2023 07:00:00 Источник Nasdaq GlobeNewswire

Immunocore announces initial Phase 1 safety and pharmacodynamic activity data with first soluble TCR therapy for people living with HIV

22 фев 2023 07:00:00 Источник Nasdaq GlobeNewswire

Immunocore to present at upcoming investor conferences

01 фев 2023 07:00:00 Источник Nasdaq GlobeNewswire

Immunocore announces strategic priorities including pipeline expansion for 2023 -2024

09 янв 2023 07:00:00 Источник Nasdaq GlobeNewswire

Immunocore to present at the 41st Annual J.P. Morgan Healthcare Conference

04 янв 2023 07:00:00 Источник Nasdaq GlobeNewswire

Immunocore is awarded the Prix Galien France award for KIMMTRAK

15 дек 2022 06:00:00 Источник Nasdaq GlobeNewswire